Oncology Hematology Ambulatory Advanced Practice Provider (NP/PA)

Quick Facts

• Role: Advanced Practice Provider (NP/PA) in a high-volume outpatient hematology/oncology setting
• Focus: Complex hematologic malignancies and cellular therapy/transplant patients

Description

Provide comprehensive clinical care to patients with complex hematologic malignancies in an ambulatory setting. Manage scheduled and urgent needs across the continuum of care, including new and established visits, treatment clearance/monitoring, symptom and toxicity management, lab/diagnostic interpretation, medication management, and supportive care. Participate in longitudinal care for patients receiving CAR-T cell therapy, bispecific antibody therapy, and both autologous and allogeneic stem cell transplantation, with prompt recognition of complications and appropriate escalation.

Responsibilities

• Care for patients with leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, and other hematologic malignancies
• Manage scheduled and urgent outpatient visits throughout treatment
• Review and interpret laboratory and diagnostic findings
• Provide symptom, toxicity, and supportive care; manage medications
• Coordinate with physicians and multidisciplinary teams to ensure continuity between inpatient and outpatient care
• Rapidly evaluate acute concerns and identify complications needing escalation
• Support cellular therapy and transplant care, including:
  • CAR-T: pre-treatment readiness, lymphodepletion/treatment coordination, post-infusion monitoring, CRS/ICANS and cytopenia/infection management
  • Bispecific antibodies: step-up dosing support, ongoing monitoring, toxicity assessment, longitudinal follow-up
  • Autologous stem cell transplant: pre-transplant readiness, mobilization/collection coordination, conditioning, recovery, outpatient follow-up; infection/cytopenia/mucositis/GI/nutrition/hydration monitoring
  • Allogeneic stem cell transplant: longitudinal infection/cytopenia/medication toxicity and immunosuppression complication monitoring; acute and chronic GVHD monitoring; education and complex medication management

Benefits

• Improved patient access and expanded provider capacity
• Continuity of care between inpatient and outpatient settings
• Safe, timely, high-quality care for medically vulnerable hematology, transplant, and cellular therapy patients